Evidence map›Paper›PMID 32408657›Full record

ArticleMolecules (Basel, Switzerland)2020

Virtual Screening and the In Vitro Assessment of the Antileishmanial Activity of Lignans.

Mayara Dos Santos Maia, Joanda Paolla Raimundo E Silva, Thaís Amanda de Lima Nunes, Julyanne Maria Saraiva de Sousa, Gabriela Cristina Soares Rodrigues, Alex France Messias Monteiro, Josean Fechine Tavares, Klinger Antonio da Franca Rodrigues, Francisco Jaime B Mendonça-Junior, Luciana Scotti and 1 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. AnMini reviews in medicinal chemistry · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Challenges and Tools for In VitroPathogens (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mayara Dos Santos MaiaLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.
Joanda Paolla Raimundo E SilvaMulti-User Characterization and Analysis Laboratory, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.
Thaís Amanda de Lima NunesInfectious Diseases Laboratory, Federal University of Parnaíba Delta, São Benedito, Parnaíba-PI 64202-020, Brazil.
Julyanne Maria Saraiva de SousaInfectious Diseases Laboratory, Federal University of Parnaíba Delta, São Benedito, Parnaíba-PI 64202-020, Brazil.
Gabriela Cristina Soares RodriguesLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.
Alex France Messias MonteiroLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.
Josean Fechine TavaresMulti-User Characterization and Analysis Laboratory, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.ORCID 0000-0003-0293-2605
Klinger Antonio da Franca RodriguesInfectious Diseases Laboratory, Federal University of Parnaíba Delta, São Benedito, Parnaíba-PI 64202-020, Brazil.ORCID 0000-0003-3904-3529
Francisco Jaime B Mendonça-JuniorLaboratory of Synthesis and Drug Delivery, State University of Paraíba, João Pessoa-PB 58071-160, Brazil.ORCID 0000-0003-3588-833X
Luciana ScottiLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.ORCID 0000-0003-1866-4107
Marcus Tullius ScottiLaboratory of Cheminformatics, Program of Natural and Synthetic Bioactive Products (PgPNSB), Health Sciences Center, Federal University of Paraíba, João Pessoa-PB 58051-900, Brazil.ORCID 0000-0003-4863-8057

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 308590/2017-1Conselho Nacional de Desenvolvimento Científico e Tecnológico 309648/2019-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 431254/2018-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

Leishmaniasis is endemic in at least 98 countries. Due to the high toxicity and resistance associated with the drugs, we chose lignans as an alternative, due to their favorable properties of absorption, distribution, metabolism, excretion, and toxicity (ADMET). To investigate their leishmanicidal potential, the biological activities of a set of 160 lignans were predicted using predictive models that were built using data for

Indexed as

Drug DesignLignansMolecular Docking SimulationAntiprotozoal AgentsDrug Evaluation, PreclinicalLeishmania braziliensisLeishmania majorAntiprotozoal AgentsLignanscomputer-aided drug designleishmaniasislignanmolecular dockingvirtual screening

Identifiers

PMID32408657
PMCPMC7288103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.